Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19
April 15, 2020 — 05:55 CST
This Data Is Locked!
This area is available only to Subscribers.
SHIJIAZHUANG, China, April 15, 2020 /PRNewswire/ -- On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
